Reports on the flaws found by researchers in the U.S. who conducted a review of several double-blind, placebo controlled clinical trials of nicotine replacement therapy (NRT). Role of the therapy in preventing expectancy bias in clinical research; Impact of the limited number of papers analyzed on the study; Role of few NRT trials in assessing for blindness.
Published
2004
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.